Tech Blog
Contact Us

Overview

The question isn’t whether clinicians will use AI for clinical guidance. It’s whether that AI has been rigorously evaluated for enterprise readiness.

AI is already in the exam room. Clinicians are querying large language models for drug interactions, differential diagnoses, and treatment guidance; with the AMA reporting that nearly 40% of surveyed clinicians use AI for summaries of research and standards of care. However, this may be done with limited visibility into how those systems were built, tested, or constrained. The tools exist. The adoption is happening. The missing piece, in most cases, is the evaluation rigor that should precede clinician usage.

At Abridge, we believe that enterprise AI in healthcare must be trustworthy at scale, and that starts with being transparent about our evaluation processes and guardrails.

Contextualizing CDS within the Abridge Workflow

Abridge now surfaces real-time, context-aware clinical decision support (CDS) directly within the encounter workflow with its Abridge AI feature. Powered by validated content from a growing body of sources, including UpToDate®, this functionality enables Abridge to deliver relevant clinical and treatment insights to clinicians at the point of conversation, without a separate search or extra clicks.

To use this capability, the clinician user can either select from a suggested prompt or write their own in a panel adjacent to the note content. As this capability lives within Abridge’s interface, not the documentation itself, clinicians can choose whether to act on or incorporate the surfaced information.

Comprehensive Offline Evaluations of Accuracy and Safety

The Abridge science team evaluates responses from our approach to CDS across three complementary dimensions before it’s considered ready for clinical use.

  • Clinical Evaluations measure whether CDS responses contain relevant clinical content. Each case evaluated is scored against a rubric built by multiple physicians who independently review a real, de-identified encounter, which is then calibrated to a common evaluation rubric. The evaluation set includes over 1,000 rubrics — a material increase over the size of existing benchmarks that use real encounters, like the NOHARM study.
  • Boundary Adversarial Evaluations test how the system handles high-risk inputs: directly harmful prompts, scope violations, attempts to bypass clinical judgment, discriminatory care scenarios, jailbreaks, and medicolegal edge cases.
  • Clinical Safety Evaluations look at responses for potentially dangerous errors — wrong drugs, missed critical diagnoses, harmful management advice, and medical misinformation. Flagged cases are manually reviewed by clinicians. The system currently scores 99.5% across 1,000+ cases. In the small number of cases where potential safety issues were identified, most have been due to limitations in source material. In those instances, we share feedback to help strengthen our collective clinical knowledge base.

Moving Beyond Offline Evaluation to Real-World Complexity

Even when based on real patient encounters, no offline evaluation fully replicates the complexity of real-world clinical workflows. That’s why our evaluation strategy extends well beyond the lab. Throughout the pre-release process for Abridge’s CDS capabilities, our clinical team conducted hundreds of queries across a wide range of medical specialties, designed to test the system and identify failure modes that only real-world complexity can surface. After internal testing, we first released to a small group of clinicians at highly-engaged preview partners before releasing to the entire departments at designated organizations. This is an ongoing practice that continuously informs how we refine both the product and the evaluation pipeline itself.

Every expansion of Abridge AI has been earned through this rigor and analysis. We move to general availability only when real-world performance validates the high level of safety and accuracy we observed in offline testing. We maintain the ability to tune or roll back at any stage, because responsible deployment means never fully letting go of the wheel. Real-world feedback continuously loops back into our evaluation framework, so the system is being tested against the complexity of actual clinical practice.

Built for Every Clinician

Abridge surfaces the same evidence-based information to every clinician, at the moment they need it. The learning happens alongside the work. The judgment stays with the human. That’s by design.

We believe that transparency in how AI is evaluated is important to ensure trustworthiness at scale. We plan to release further, in-depth evaluation research across CDS as the year continues, contributing to the evaluation evidence base and supporting responsible and more effective use across the board. Our previously published science and research includes a look into hallucinations, scaling specialty models, and more.

Share

In this series:

Recent posts

Clinical conversations are full of specialized language, multiple speakers, and noisy environments — and transcription errors propagate through the whole pipeline. How we built an LLM-based ASR model, tuned with reinforcement learning and contextual biasing, to recognize medical terminology more reliably…

No single model is the right tool for every clinical task, which is why we use frontier models and specialized in-house models together. Why we build in-house clinical models, why it’s hard, and how we approach the work — so clinicians never have to think about which model is behind their tools…

Beyond offline evaluation and online monitoring, “in-line” evaluations run inside the note generation pipeline itself. How our Editors detect and correct issues before a clinician ever sees the draft — and how we validate the Editors themselves…

User feedback carries signal of what clinicians care about in real encounters — but it arrives as unstructured comments and note edits. How we decompose that feedback into atomic units and classify it against an error taxonomy of over 50 categories…

Our online evaluations run continually on our deployed note generation systems. Every day we evaluate thousands of notes across many quality dimensions — work that relies on LLM judges, and on validating those judges against expert clinician judgment…

All new features and product improvements at Abridge undergo “offline” pre-deployment evaluation. These evaluations are conducted on systems that are not yet deployed with our partners, enabling experimentation without risking adverse impacts…

Note generation was the first product we built at Abridge, the first product with which we earned the trust of our users, and the first product on which we honed our evaluation framework. Here we show how we answer the question of what makes a great clinical note…

Reliable evaluation is a baseline requirement for developing AI products that users can trust. At Abridge, where our products are trusted by tens of thousands of clinicians, we honor and maintain that trust through rigorous evaluation of those products…

A few months ago, I sat down for a filmed roundtable with another Abridge clinician builder and two product leaders. The topic was Clinical Decision Support, a new product that surfaces evidence-based information during the patient encounter…

A patient arrives in the ED with a bleeding scalp laceration. Abridge surfaces a perfect match for a clinical trial evaluating machine-learning-based methods to assess bleeding — on paper, correct; in practice, wrong…

The question isn’t whether clinicians will use AI for clinical guidance. It’s whether that AI has been rigorously evaluated for enterprise readiness…